Background illustration for clinical trials search

Paid Clinical Trials Alabama

Discover 1,107 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Featured

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

for
Episodic Migraine
Location: Morristown NJ, Philadelphia PA, Franklin VA, Miami FL,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05711394

Phase3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Burlington MA, East Greenwich RI, Framingham MA,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Durham NC,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase1, Recruiting
Active & Responsive

Empowering Faith-based Communities to Provide Personalized Diabetes Self-management Education and Support (DSMES) in the Magic City

for
Blood Cholesterol, Blood Pressure Monitoring, Weight Change,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT07556354

Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Brewer ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: New York NY, Belleville NJ, East Brunswick NJ,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase3, Recruiting
Active & Responsive

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: Providence RI, New Haven CT, Quebec, New York NY,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06647498

Phase2, Phase3, Recruiting
Active & Responsive

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Boston MA, New Haven CT, Philadelphia PA, Durham NC,
Sponsor: Epiminder America, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07110454

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: New Bedford MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

for
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 12+

Code: NCT06338995

Phase3, Recruiting
Active & Responsive

Cannabis and Processing Emotions Study

for
Cannabis Use Disorder, Severe
Location: Auburn AL
Sponsor: Auburn University

Sex: All

Age: 18 - 50

Code: NCT06907979

Recruiting
Active & Responsive

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: Providence RI, New Haven CT, Quebec, New York NY,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05552157

Phase2, Phase3, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Boston MA, East Greenwich RI, Waterbury CT, Brooklyn NY,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07231419

Phase3, Recruiting
Active & Responsive

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for
Generalized Myasthenia Gravis
Location: Boston MA, New Haven CT, New Hyde Park NY,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04202341

Recruiting
Active & Responsive

Belimumab With Rituximab for Primary Membranous Nephropathy

for
Membranous Nephropathy, Nephrotic Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03949855

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

for
Sickle Cell Disease
Location: The Bronx NY, Philadelphia PA, Easton PA, Baltimore MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06439082

Phase3, Recruiting
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Portland ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase3, Recruiting
Active & Responsive

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

for
Platinum-resistant Ovarian Cancer,
Location: Stony Brook NY, Greenville NC, Silver Spring MD,
Sponsor: Genelux Corporation

Sex: Female

Age: 18+

Code: NCT05281471

Phase3, Recruiting

Popular cities in Alabama

MobileHuntsvilleAuburnTuscaloosaDothanBirminghamMontgomery